These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8037401)

  • 1. Adenosine in the termination of albuterol-induced supraventricular tachycardia.
    Cook P; Scarfone RJ; Cook RT
    Ann Emerg Med; 1994 Aug; 24(2):316-9. PubMed ID: 8037401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine for salbutamol-induced supraventricular tachycardia.
    Trachsel D; Newth CJ; Hammer J
    Intensive Care Med; 2007 Sep; 33(9):1676. PubMed ID: 17503014
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence of supraventricular tachycardia after inhaled short-acting beta agonist treatment in children.
    Woodward S; Mundorff M; Weng C; Gamboa DG; Johnson MD
    J Asthma; 2021 Apr; 58(4):471-480. PubMed ID: 31902263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
    Li XM; Ge HY; Liu XQ; Shi L; Guo BJ; Li MT; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li AJ; Zhang YY
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):13-18. PubMed ID: 29342991
    [No Abstract]   [Full Text] [Related]  

  • 5. Recalcitrant Supraventricular Tachycardia: Occult Albuterol Toxicity Due to a Factitious Disorder.
    Wills BK; Kwan C; Bailey M; Johnson L; Allan N
    J Emerg Med; 2015 Oct; 49(4):436-8. PubMed ID: 26162766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diastolic hypotension is an unrecognized risk factor for β-agonist-associated myocardial injury in children with asthma.
    Sarnaik SM; Saladino RA; Manole M; Pitetti RA; Arora G; Kuch BA; Orr RA; Felmet KA
    Pediatr Crit Care Med; 2013 Jul; 14(6):e273-9. PubMed ID: 23823208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supraventricular tachycardia after nebulized salbutamol therapy in a neonate: case report.
    Say B; Degirmencioglu H; Gozde Kanmaz Kutman H; Uras N; Dilmen U
    Arch Argent Pediatr; 2015 Apr; 113(2):e98-100. PubMed ID: 25727842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Management of Refractory and Unstable Pediatric Supraventricular Tachycardia.
    Lewis J; Arora G; Tudorascu DL; Hickey RW; Saladino RA; Manole MD
    J Pediatr; 2017 Feb; 181():177-182.e2. PubMed ID: 27912926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department.
    Díaz-Parra S; Sánchez-Yañez P; Zabala-Argüelles I; Picazo-Angelin B; Conejo-Muñoz L; Cuenca-Peiró V; Durán-Hidalgo I; García-Soler P
    Pediatr Emerg Care; 2014 Jun; 30(6):388-93. PubMed ID: 24849273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal dose of adenosine effective for supraventricular tachycardia in children.
    Qureshi AU; Hyder SN; Sheikh AM; Sadiq M
    J Coll Physicians Surg Pak; 2012 Oct; 22(10):648-51. PubMed ID: 23058149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trial of adenosine for the termination of supraventricular tachycardia in infancy: a case report.
    Wu JR; Huang TY; Lo WS; Wu SN
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Jun; 8(6):338-41. PubMed ID: 1404538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraventricular tachycardia: a complication of nebulized albuterol.
    Keller KA; Bhisitkul DM
    Pediatr Emerg Care; 1995 Apr; 11(2):98-9. PubMed ID: 7596887
    [No Abstract]   [Full Text] [Related]  

  • 13. Recurrent supraventricular tachycardia as a complication of nebulized albuterol treatment.
    Duane M; Chandran L; Morelli PJ
    Clin Pediatr (Phila); 2000 Nov; 39(11):673-7. PubMed ID: 11110370
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenosine conversion of supraventricular tachycardia associated with high-dose epinephrine therapy for cardiac arrest.
    Gerhardt RT; Furlong R; Schrank K; Ress BD
    Prehosp Disaster Med; 1999; 14(2):97-9. PubMed ID: 10558324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine for the treatment of paroxysmal supraventricular tachycardia in full-term and preterm newborn infants.
    Paret G; Steinmetz D; Kuint J; Hegesh J; Frand M; Barzilay Z
    Am J Perinatol; 1996 Aug; 13(6):343-6. PubMed ID: 8865979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful intraosseous adenosine administration in a newborn infant with supraventricular tachycardia.
    Fidancı İ; Güleryüz OD; Yenice ÖD
    Turk J Pediatr; 2020; 62(6):1064-1068. PubMed ID: 33372446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency department management of the pediatric patient with supraventricular tachycardia.
    Manole MD; Saladino RA
    Pediatr Emerg Care; 2007 Mar; 23(3):176-85; quiz 186-9. PubMed ID: 17413437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed adenosine therapy is associated with the refractory supraventricular tachycardia in children.
    Kim JH; Jung JY; Lee SU; Park JW; Choi JY
    Am J Emerg Med; 2020 Nov; 38(11):2291-2296. PubMed ID: 31787438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adenosine in terminating catecholamine-dependent supraventricular tachycardia.
    Lauer MR; Young C; Liem LB; Sung RJ
    Am J Cardiol; 1994 Jan; 73(1):38-42. PubMed ID: 8279375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraventricular tachycardia in the pediatric primary care setting: Age-related presentation, diagnosis, and management.
    Schlechte EA; Boramanand N; Funk M
    J Pediatr Health Care; 2008; 22(5):289-99. PubMed ID: 18761230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.